Show simple item record

dc.contributor.authorSrivastava, Raghvendra Men_US
dc.contributor.authorJie, Hyun-baeen_US
dc.contributor.authorFerrone, Soldanoen_US
dc.contributor.authorFerris, Robert Len_US
dc.date.accessioned2014-07-07T18:14:54Z
dc.date.issued2013en_US
dc.identifier.citationSrivastava, Raghvendra M, Hyun-bae Jie, Soldano Ferrone, and Robert L Ferris. 2013. “STAT1 contributes to HLA class I upregulation and CTL reactivity after anti-EGFR mAb cetuximab therapy in head and neck cancer patients.” Journal for Immunotherapy of Cancer 1 (Suppl 1): P175. doi:10.1186/2051-1426-1-S1-P175. http://dx.doi.org/10.1186/2051-1426-1-S1-P175.en
dc.identifier.issn2051-1426en
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:12407007
dc.description.abstracten
dc.language.isoen_USen
dc.publisherBioMed Centralen
dc.relation.isversionofdoi:10.1186/2051-1426-1-S1-P175en
dc.relation.hasversionhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991086/pdf/en
dash.licenseLAAen_US
dc.titleSTAT1 contributes to HLA class I upregulation and CTL reactivity after anti-EGFR mAb cetuximab therapy in head and neck cancer patientsen
dc.typeOtheren_US
dc.description.versionVersion of Recorden
dc.relation.journalJournal for Immunotherapy of Canceren
dash.depositing.authorFerrone, Soldanoen_US
dc.date.available2014-07-07T18:14:54Z
dc.identifier.doi10.1186/2051-1426-1-S1-P175*
dash.contributor.affiliatedFerrone, Soldano


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record